Atlas Trials

A Phase I Study to Assess the Safety and Tolerability of BL0006 for Patients With Advanced Solid Tumours

Clinical trial NCT06247657 · UNKNOWN

Trial details

NCT number
NCT06247657
Sponsor
Shanghai Best-Link Bioscience, LLC
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Tumor
Start date
2024-01-03
Primary completion
2024-10-01
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.